The Use of Nanotechnology in Drug Delivery for Neurological Disorders

Abstract

Nanotechnology has revolutionized drug delivery systems, particularly in the treatment of neurological disorders, where the blood-brain barrier (BBB) presents a significant challenge. This article explores the applications of nanotechnology in overcoming this barrier, enhancing drug bioavailability, and improving therapeutic outcomes. Nanoparticles, including liposomes, dendrimers, and solid lipid nanoparticles, have shown promise in targeted drug delivery, minimizing side effects, and providing controlled release mechanisms. The paper discusses the role of nanocarriers in crossing the BBB, their design considerations, and the various strategies employed to optimize drug delivery. Additionally, the article covers recent advancements, challenges, and future directions in the field of nanomedicine for neurological disorders.